Title |
Emotions and scope effects in the monetary valuation of health
|
---|---|
Published in |
HEPAC Health Economics in Prevention and Care, March 2017
|
DOI | 10.1007/s10198-017-0885-7 |
Pubmed ID | |
Authors |
María V. Avilés Blanco, Raúl Brey, Jorge Araña, José Luis Pinto Prades |
Abstract |
This study presents evidence on the role of emotions in the monetary evaluation of health technologies, namely, drug-eluting stents (DES) in our case. It is shown that subjects who are very afraid of having to undergo an angioplasty are: (a) less sensitive to the size of the risk reduction provided by DES and (b) willing to pay more. The lack of scope sensitivity questions the normative validity of the responses of highly emotional subjects. We provide evidence of this effect using what we call the cognitive-emotional random utility model and the responses of a face-to-face, computer-assisted personal interview survey conducted in a representative sample of the Spanish general population (n = 1663). |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 15 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 3 | 20% |
Researcher | 3 | 20% |
Librarian | 2 | 13% |
Student > Bachelor | 2 | 13% |
Professor | 1 | 7% |
Other | 1 | 7% |
Unknown | 3 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Economics, Econometrics and Finance | 4 | 27% |
Psychology | 3 | 20% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 7% |
Agricultural and Biological Sciences | 1 | 7% |
Business, Management and Accounting | 1 | 7% |
Other | 2 | 13% |
Unknown | 3 | 20% |